Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancers, Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02493972
What this trial is testing

Interest of the Manual Exploration as a Supplement to the Coelioscopy in the Evaluation of the Resectability of Peritoneal Carcinosis

Who this might be right for
Ovarian Cancer With Peritoneal Carcinosis
Centre Francois Baclesse 40
Not applicableWithdrawnNCT01445275
What this trial is testing

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Who this might be right for
Fallopian Tube CarcinomaHereditary Breast and Ovarian Cancer SyndromeOvarian Carcinoma+1 more
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00653328
What this trial is testing

Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Vanderbilt-Ingram Cancer Center 15
Not applicableStudy completedNCT00058032
What this trial is testing

CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women

Who this might be right for
Ovarian Cancer
University College, London 202,638
Testing effectiveness (Phase 2)Looking for participantsNCT07033819
What this trial is testing

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

Who this might be right for
Ovarian Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 48
Testing effectiveness (Phase 2)UnknownNCT04720807
What this trial is testing

Letrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 30
Not applicableStudy completedNCT00145392
What this trial is testing

Body Composition, Glucose Metabolism, Insulin Resistance and Gene Expression in Muscle Cells in Healthy Overweight Women

Who this might be right for
ObesityType 2 DiabetesPolycystic Ovary Syndrome
Odense University Hospital 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272
What this trial is testing

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more
23andMe, Inc. 141
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Study completedNCT00352300
What this trial is testing

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

Who this might be right for
Fallopian Tube CarcinomaInfectious DisorderNeutropenia+4 more
Gynecologic Oncology Group 43
Testing effectiveness (Phase 2)Ended earlyNCT02100007
What this trial is testing

ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors

Who this might be right for
Solid Tumors
MEI Pharma, Inc. 46
Early research (Phase 1)Looking for participantsNCT06010875
What this trial is testing

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Renal Cell CarcinomaOvarian CancerCervix Cancer+2 more
Chongqing Precision Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Study completedNCT03464201
What this trial is testing

Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study

Who this might be right for
Ovarian Cancer
Grupo Español de Tumores Huérfanos e Infrecuentes 16
Not applicableLooking for participantsNCT05649072
What this trial is testing

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Who this might be right for
Ovarian CancerBreast CancerColorectal Cancer
M.D. Anderson Cancer Center 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT04503265
What this trial is testing

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more
AtlasMedx, Incorporated 122
Not applicableLooking for participantsNCT05858307
What this trial is testing

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

Who this might be right for
Anti-Müllerian HormonePolycystic Ovarian SyndromePremature Ovarian Insufficiency+1 more
Chinese University of Hong Kong 300
Not applicableLooking for participantsNCT06907771
What this trial is testing

Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
University Hospital, Strasbourg, France 130
Large-scale testing (Phase 3)Study completedNCT00003644
What this trial is testing

Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer

Who this might be right for
Ovarian Cancer
Gynecologic Oncology Group 571
Early research (Phase 1)UnknownNCT05273944
What this trial is testing

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients

Who this might be right for
Breast CancerOvarian Cancer
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT01068509
What this trial is testing

Ovarian Cancer Vaccine for Patients in Remission

Who this might be right for
Epithelial Ovarian Cancer
Prima BioMed Ltd 63
Next Page